Variant Gene Risk Allele Score vda Association Type Original DB Sentence supporting the association PMID PMID Year
dbSNP: rs121913483
rs121913483
G 0.820 CausalMutation CLINVAR

dbSNP: rs121913482
rs121913482
T 0.800 CausalMutation CLINVAR

dbSNP: rs121913530
rs121913530
0.800 GeneticVariation UNIPROT

dbSNP: rs121913530
rs121913530
G 0.800 CausalMutation CLINVAR

dbSNP: rs78311289
rs78311289
C 0.800 CausalMutation CLINVAR

dbSNP: rs104894228
rs104894228
A 0.700 CausalMutation CLINVAR

dbSNP: rs104894229
rs104894229
A 0.700 CausalMutation CLINVAR

dbSNP: rs104894230
rs104894230
G 0.700 CausalMutation CLINVAR

dbSNP: rs104894230
rs104894230
A 0.700 CausalMutation CLINVAR

dbSNP: rs104894360
rs104894360
A 0.700 CausalMutation CLINVAR

dbSNP: rs121434629
rs121434629
A 0.700 GeneticVariation CLINVAR

dbSNP: rs121913105
rs121913105
C 0.700 CausalMutation CLINVAR

dbSNP: rs137853294
rs137853294
RB1
T 0.700 CausalMutation CLINVAR

dbSNP: rs1555515731
rs1555515731
G 0.700 CausalMutation CLINVAR

dbSNP: rs28897728
rs28897728
0.700 GeneticVariation UNIPROT

dbSNP: rs28931614
rs28931614
A 0.700 CausalMutation CLINVAR

dbSNP: rs28933068
rs28933068
G 0.700 CausalMutation CLINVAR

dbSNP: rs4647924
rs4647924
G 0.700 CausalMutation CLINVAR

dbSNP: rs587776783
rs587776783
A 0.700 CausalMutation CLINVAR

dbSNP: rs786201675
rs786201675
ATM
C 0.700 GeneticVariation CLINVAR

dbSNP: rs156697
rs156697
0.020 GeneticVariation BEFREE Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0-1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9-1.8; P for trend=0.06). 22306368

2012

dbSNP: rs1484761909
rs1484761909
0.010 GeneticVariation BEFREE Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0-1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9-1.8; P for trend=0.06). 22306368

2012

dbSNP: rs758057623
rs758057623
0.010 GeneticVariation BEFREE Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0-1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9-1.8; P for trend=0.06). 22306368

2012

dbSNP: rs7975
rs7975
0.010 GeneticVariation BEFREE Bladder cancer risk overall was associated with GSTO2 Asn142Asp (homozygous; OR=1.4; 95% CI: 1.0-1.9; P for trend=0.06) and GSTZ1 Glu32Lys (homozygous; OR=1.3; 95% CI: 0.9-1.8; P for trend=0.06). 22306368

2012

dbSNP: rs1476413
rs1476413
0.010 GeneticVariation BEFREE Bladder cancer cases were also 60% less likely to be homozygotes for the A allele in rs1476413 in MTHFR compared to controls (OR = 0.40; 95% CI = 0.18-0.88). 22747749

2012